Physician profile
Bethanie S Delaney
NPI 1306043906
$1,151.38
in general payments reported to CMS, 2019-2025
16 companies · $232 in 2025
The $232 reported for 2025 was more than what 84% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $212 · 2023: $533 · 2024: $175 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $198.55 | 2023 | Myrisk |
| Astellas Pharma US INC | $184.43 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $171.86 | 2022-2023 | |
| Organon LLC | $137.06 | 2022-2024 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $133.39 | 2022-2025 | |
| Sage Therapeutics, LLC | $87.36 | 2024 | |
| Dexcom, INC. | $61.40 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $40.53 | 2022-2023 | Evenity, Prolia |
| Sumitomo Pharma America, INC. | $31.71 | 2023 | Myfembree |
| Millicent US INC | $16.54 | 2025 | Femlyv, Intrarosa |
| Exeltis, USA INC. | $15.64 | 2023 | Slynd |
| Myovant Sciences INC. | $15.45 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $15.33 | 2023 | Vivjoa |
| Pacira Pharmaceuticals Incorporated | $15.00 | 2023 | Exparel, Iovera |
| Medtronic, INC. | $14.03 | 2023 | Venaseal |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $13.10 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethanie Delaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.